Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oxurion NV successfully conducted its Extraordinary General Meeting (EGM) on July 24, 2024, with all agenda items receiving approval from shareholders. The Leuven-based biopharmaceutical company, specializing in innovative treatments for retinal diseases, has made the EGM documents available for review on its website.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
